While there may be negative connotations attached to the term “palliative care,” this type of care could be called “supportive team care” to better express its potential to educate and care for patients with chronic illnesses such as multiple sclerosis (MS), said June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.
While there may be negative connotations attached to the term “palliative care,” this type of care could be called “supportive team care” to better express its potential to educate and care for patients with chronic illnesses such as multiple sclerosis (MS), said June Halper, MSN, APN-C, MSCN, FAAN, chief executive officer, Consortium of Multiple Sclerosis Centers.
Transcript
Does palliative care play an important role in multiple sclerosis, and do you think there is a need for greater understanding and uptake of this type of care?
Well, let’s differentiate palliative care from hospice care. Hospice care, of course, is covered by Medicare, most insurance companies. Hospice care usually is put in place when someone has less than 6 months to live, and usually it’s a chronic but fatal disease, such as heart disease or cancer. In multiple sclerosis, on the other hand, when the person is diagnosed, say the average of 22 or 23, they can expect to live a fairly long life expectancy. And in many cases, if they’re not treated right away or they have a very serious disease course, they might get to a point when no medication for disease modification is eligible—they’re eligible for that. So, it might get to a point where care they are eligible for is palliative care.
Palliative care is, in my mind, supportive team care. It’s not just the doctor or the nurse, it’s the whole team. And that could last for a long, long time. So palliative care in MS is one of the very important models of care that the CMSC, or the Consortium of MS Centers, has just developed a consensus statement on and it’s now on our website. And it’s an educational model we just started to teach at our annual meeting. We had our first session there where we talked about cases and models and how do you manage it and who’s involved and again, people certainly get frightened by the word “palliative care,” so one of the things we’re looking at is changing the name to supportive team care and maybe that is more appropriate. But it’s a real model of care and it means a lifelong, supportive network of people that come in and educate, provide care, and support the patient through the difficult times of possibly an increasing disability.
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Distinguishing Biomarkers Identified in MS Outcomes
March 19th 2024Results from this cohort study found that levels of glial fibrillary acid protein, cerebral spinal fluid, and neurofilament heavy chain are distinguishable biomarkers that are associated with disease outcomes in multiple sclerosis (MS).
Read More
FDA Issues CRL for Glatiramer Acetate Depot for Relapsing Forms of MS
March 11th 2024The FDA has declined to approve glatiramer acetate (GA) depot in the treatment of relapsing types of multiple sclerosis (MS), issuing a complete response letter (CRL) for the long-acting, injectable form of GA.
Read More
Getting to Know Dr Fabiola Molina, Hospitalist
February 26th 2024Fabiola Molina, MD, MHS, is a practicing hospitalist and assistant professor of medicine at Yale School of Medicine and Yale New Haven Hospital. An immigrant from Mexico, her experiences straddling 2 worlds, while attempting to navigate with her family the complicated safety-net system for health care in Texas, were key influences to her ardent focus on health equity.
Read More